Huiyu Pharmaceutical (688553.SH) and its subsidiaries have obtained overseas listing permits for multiple products.

Zhtng Cijng APP News, Huiyu Pharmaceutical (688553.SH) announced that the company and its subsidiaries Seacross Pharma (Europe) Ltd. and Seacross Pharmaceuticals Ltd. have recently received approvals from the Danish Medicines Agency, the German Federal Institute for Drugs and Medical Devices, the State Drug Control Agency of the Republic of Uzbekistan, and the Drug Administration of Bangladesh for the company's products including Paclitaxel for Injection (Albumin Bound), Cyclophosphamide for Injection, Paclitaxel Injection, Concentrated Solution of Zoledronic Acid for Injection, and Azacitidine for Injection.